Steve O'Loughlin is Principal Financial Officer at Actinium Pharmaceuticals, Inc. (ATNM). They have made 3 open-market trades across 1 company since 2017, most recently 2018-12-10.
CIK 0001615840
3 open-market purchases totalling $14K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATNM | 35,500 | $46K |
Shares reported on the most recent Form 4, priced at the 2018-12-10 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.